Renovaro(RENB.US) 10% Shareholder Sells US$168.5K in Common Stock
$Renovaro(RENB.US)$ 10% Shareholder William Anderson Wittekind sold 110K shares of common stock on Jul 3, 5, 2024 at an average price of $1.53 for a total value of $168.5K. Source: Announce
Renovaro(RENB.US) 10% Shareholder Sells US$146.81K in Common Stock
$Renovaro(RENB.US)$ 10% Shareholder William Anderson Wittekind sold 94,553 shares of common stock on Jul 1, 2, 2024 at an average price of $1.55 for a total value of $146.81K.Source: Announcement What
Renovaro Biosciences Board Member Leni Boeren Resigns
Renovaro(RENB.US) 10% Shareholder Sells US$132.11K in Common Stock
$Renovaro(RENB.US)$ 10% Shareholder William Anderson Wittekind sold 84,671 shares of common stock on Jun 25, 26, 27, 2024 at an average price of $1.56 for a total value of $132.11K.Source: Announcemen
Renovaro(RENB.US) 10% Shareholder Sells US$79,000 in Common Stock
$Renovaro(RENB.US)$ 10% Shareholder William Anderson Wittekind sold 50,000 shares of common stock on Jun 14, 2024 at an average price of $1.58 for a total value of $79,000.Source: Announcement What is
12 Health Care Stocks Moving In Friday's After-Market Session
GainersKineta (NASDAQ:KA) shares moved upwards by 28.5% to $0.67 during Friday's after-market session. The company's market cap stands at $8.1 million. iSpecimen (NASDAQ:ISPC) stock moved upwards by 1
Express News | Renovaro, Inc. Announces $10 Million in Equity Committed
Form 144 | Renovaro(RENB.US) 10% Stockholder Proposes to Sell 1.74 Million in Common Stocks
SEC FILLINGS DISCLOSED/ Jun 11, $Renovaro(RENB.US)$ 10% Stockholder William Anderson Wittekind intends to sell 1.2 million shares of its common stock on May 30, with a total market value of approximat
Why Skye Bioscience Shares Are Trading Lower By 19%? Here Are Other Stocks Moving In Monday's Mid-Day Session
Shares of Skye Bioscience, Inc. (NASDAQ:SKYE) fell sharply during Monday's session after the company announced its SBI-100 Ophthalmic Emulsion Phase 2a trial did not achieve target product profile and
12 Health Care Stocks Moving In Monday's Intraday Session
GainersSeres Therapeutics (NASDAQ:MCRB) stock moved upwards by 34.0% to $0.82 during Monday's regular session. The company's market cap stands at $124.5 million. Renovaro (NASDAQ:RENB) shares increase
Renovaro Shares Resume Trade
Renovaro Shares Resume Trade
Renovaro Shares Halted On Circuit Breaker To The Upside, Stock Now Up 81.4%
Renovaro Shares Halted On Circuit Breaker To The Upside, Stock Now Up 81.4%
Form 144 | Renovaro(RENB.US) 10% Stockholder Proposes to Sell 398.82K in Common Stocks
SEC FILLINGS DISCLOSED/ Jun 6, $Renovaro(RENB.US)$ 10% Stockholder William Anderson Wittekind intends to sell 275.05K shares of its common stock on Jun 6, with a total market value of approximately $3
American Airlines, Bank OZK, Biohaven Among Premarket Losers' Pack
Renovaro Inc-Co and Amsterdam UMC Cancer Center prepare to advance cancer immunotherapy
Renovaro Inc-Co and Amsterdam UMC Cancer Center prepare to advance cancer immunotherapy
Renovaro Inc. - Proposed new corporate headquarters will be located in Amsterdam, the Netherlands
Renovaro Inc. - Proposed new corporate headquarters will be located in Amsterdam, the Netherlands
Renovaro Inc. signed a memorandum of understanding to establish a joint venture in the Netherlands to pioneer the next generation of personalized cancer immunotherapy
Renovaro Inc. signed a memorandum of understanding to establish a joint venture in the Netherlands to pioneer the next generation of personalized cancer immunotherapy
Express News | Renovaro Inc - Proposed Newco Will Be Headquartered in Amsterdam, Netherlands
Express News | Renovaro Inc - Signed Mou to Establish Joint Company Based in Netherlands Aimed at Pioneering Next Generation of Personalized Cancer Immunotherapy
Express News | Renovaro Inc - Co and Amsterdam Umc Cancer Center Poised to Advance Cancer Immunotherapy